Showing results (111-120 of 182) with videos related to
Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 2025
MIRD Pamphlet No. 33: MIRDpvc-A Software Tool for Recovery Coefficient-Based Partial-Volume CorrectionHarry Marquis, Johan Gustafsson, C Ross Schmidtlein, et al.Journal of the Endocrine Society|September 1, 2021
Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary CarcinomaAndrew L Lin, Viviane Tabar, Robert J Young, et al.Cancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomasLisa Bodei, Daria Handkiewicz-Junak, Chiara Grana, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2025
MIRD Pamphlet No. 32: A MIRD Recovery Coefficient Model for Resolution Characterization and Shape-Specific Partial-Volume CorrectionHarry Marquis, C Ross Schmidtlein, Robin de Nijs, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2011
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsFrancesco Giammarile, Lisa Bodei, Carlo Chiesa, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 31, 2023
Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate CancerMilan Grkovski, Joseph A O'Donoghue, Brandon S Imber, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2023
MIRD Pamphlet No. 28, Part 1: MIRDcalc-A Software Tool for Medical Internal Radiation DosimetryAdam L Kesner, Lukas M Carter, Juan C Ocampo Ramos, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2015
Long-term results of PRRT in advanced bronchopulmonary carcinoidAnnapaola Mariniello, Lisa Bodei, Carmine Tinelli, et al.Cancer|July 16, 2024
Update in the management of gastroenteropancreatic neuroendocrine tumorsAndrew J H Sedlack, Diana Grace Varghese, Amirkia Naimian, et al.Pageof 19